establishing safety and care requirements for clinician-administered drugs.

{"id": "ocd-bill/b8014855-9377-48c4-a5c8-4d1d11564fc3", "session": "2026", "jurisdiction": {"id": "ocd-jurisdiction/country:us/state:nh/government", "name": "New Hampshire", "classification": "state"}, "from_organization": {"id": "ocd-organization/c95932a0-2ac1-4f14-a0c4-ade8568daac6", "name": "Senate", "classification": "upper"}, "identifier": "SB 256", "title": "establishing safety and care requirements for clinician-administered drugs.", "classification": ["bill"], "subject": [], "extras": {"LSR": "1003"}, "created_at": "2026-01-01T02:06:59.190796+00:00", "updated_at": "2026-05-28T17:02:03.165051+00:00", "openstates_url": "https://openstates.org/nh/bills/2026/SB256/", "first_action_date": "2025-01-23", "latest_action_date": "2026-05-14", "latest_action_description": "Refer for Interim Study: MA VV 05/14/2026  HJ 13", "latest_passage_date": "2026-01-07"}